Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

Guardado en:
Detalles Bibliográficos
Autores principales: John Yeakel, MD, Aarthi Kannan, BA, Nicole Hook Rattigan, PhD, Maki Yamamoto, MD, Alexey Aleshin, MD, MBA, Jeremy P. Harris, MPhil, MD, Ling Gao, MD, PhD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
circulating tumor DNA
hypofractionated radiation
Merkel cell carcinoma
T-VEC
Dermatology
RL1-803
Acceso en línea:https://doaj.org/article/83c88c6092e54f0f84f262e3833ad7ea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/83c88c6092e54f0f84f262e3833ad7ea

Ejemplares similares